Pricing

Akouos, Inc. (AKUS)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Emmanuel J. Simons
Employees:
100
645 SUMMER STREET, SUITE 200, BOSTON, MA, 02210
857-410-1818
Akouos, Inc. is developing gene therapies to restore, improve, and preserve physiologic hearing. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company was incorporated in 2016 and is based in Boston, Massachusetts.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available